Literature DB >> 9472805

Phenotypic and functional characterization of mast cells derived from renal tumor tissues.

W J Beil1, W Füreder, H Wiener, K Grossschmidt, U Maier, A Schedle, H C Bankl, K Lechner, P Valent.   

Abstract

Mast cells (MCs) originate from multipotent hematopoietic progenitor cells. However, MCs in various organs are heterogenous in terms of mediator or receptor expression and response to diverse stimuli. We characterized the phenotype and functional properties of human renal mast cells (HRMCs). Tissue was obtained from 17 patients suffering from renal tumors (transitional cell carcinoma, n = 4; renal cell carcinoma, n = 13). HRMCs were isolated by collagenase digestion. Double staining with toluidine blue and immunofluorescence using monoclonal antibodies (mAbs) revealed expression of stem cell factor (SCF)-receptor (c-kit/CD117), CD9, CD29, CD33, CD43, CD44, CD54, and CD63 on HRMCs. In contrast, HRMCs were not recognized by mAbs to CD2, CD3, CD4, CD11b, CD14, CD15, CD16, CDw17, CD19, or CD23. HRMCs were also negative for CD116 (granulocyte-macrophage colony-stimulating factor [GM-CSF] receptor alpha), CD123 (interleukin [IL]-3Ralpha), CD121a (IL-1R type I), CD122 (IL-2Rbeta), and CD127 (IL-7R) and were also found to lack C5aR (CD88). Ligand-induced activation of HRMCs through immunoglobulin (Ig)E-R or SCF-R (c-kit) resulted in histamine secretion (control: <10%; alphaIgE, 1 microg/mL: 50.12 +/-5.18%; rhSCF, 100 ng/mL: 29.24 +/- 22.39), whereas recombinant C5a, erythropoietin (EPO), IL-1 through 10, and GM-CSF exerted no effects. As determined by in situ staining, HRMCs contained tryptase, but only low or undetectable amounts of chymase. Electron microscopy confirmed the presence of MCs in renal tissues and revealed a scroll-rich granule population in HRMCs. Together, HRMCs are tryptase+, C5aR- mast cells exhibiting phenotypic and functional properties similar to those of lung MCs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472805

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Immunosurveillance function of human mast cell?

Authors:  Oner Ozdemir
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

3.  Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.

Authors:  Afsaneh Soruri; Jasmin Grigat; Ziba Kiafard; Jörg Zwirner
Journal:  BMC Immunol       Date:  2008-06-17       Impact factor: 3.615

4.  Interleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitors.

Authors:  Yuji Shimizu; Kenji Matsumoto; Yoshimichi Okayama; Kentaro Sakai; Toshitaka Maeno; Tatsuo Suga; Toru Miura; Shinji Takai; Masahiko Kurabayashi; Hirohisa Saito
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

Review 5.  Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.

Authors:  Ilaria Marech; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2014-07-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.